Recognition of cisplatin adducts by cellular proteins
- PMID: 11406166
- DOI: 10.1016/s0027-5107(01)00142-7
Recognition of cisplatin adducts by cellular proteins
Abstract
Cisplatin is a widely used chemotherapeutic agent. It reacts with nucleophilic bases in DNA and forms 1,2-d(ApG), 1,2-d(GpG) and 1,3-d(GpTpG) intrastrand crosslinks, interstrand crosslinks and monofunctional adducts. The presence of these adducts in DNA is through to be responsible for the therapeutic efficacy of cisplatin. The exact signal transduction pathway that leads to cell cycle arrest and cell death following treatment with the drug is not known but cell death is believed to be mediated by the recognition of the adducts by cellular proteins. Here we describe the structural information available for cisplatin and related platinum adducts, the interactions of the adducts with cellular proteins and the implications of these interactions for cell survival.
Similar articles
-
Recognition and repair of DNA-cisplatin adducts.Acta Biochim Pol. 2002;49(3):583-96. Acta Biochim Pol. 2002. PMID: 12422229 Review.
-
Cisplatin.Essays Biochem. 1999;34:191-211. doi: 10.1042/bse0340191. Essays Biochem. 1999. PMID: 10730196 Review.
-
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.Nature. 1999 Jun 17;399(6737):708-12. doi: 10.1038/21460. Nature. 1999. PMID: 10385126
-
Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.Nucleic Acids Res. 2000 Dec 1;28(23):4634-41. doi: 10.1093/nar/28.23.4634. Nucleic Acids Res. 2000. PMID: 11095672 Free PMC article.
-
Repair of cisplatin--DNA adducts by the mammalian excision nuclease.Biochemistry. 1996 Aug 6;35(31):10004-13. doi: 10.1021/bi960453+. Biochemistry. 1996. PMID: 8756462
Cited by
-
Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action.J Biol Inorg Chem. 2022 Mar;27(2):239-248. doi: 10.1007/s00775-022-01924-9. Epub 2022 Jan 22. J Biol Inorg Chem. 2022. PMID: 35064831 Free PMC article.
-
Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells.Mol Cell Biol. 2011 Dec;31(24):4964-77. doi: 10.1128/MCB.05258-11. Epub 2011 Oct 17. Mol Cell Biol. 2011. PMID: 22006019 Free PMC article.
-
Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells.Mol Cancer. 2011 Mar 8;10:24. doi: 10.1186/1476-4598-10-24. Mol Cancer. 2011. PMID: 21385444 Free PMC article.
-
The Human RAD5 Homologs, HLTF and SHPRH, Have Separate Functions in DNA Damage Tolerance Dependent on The DNA Lesion Type.Biomolecules. 2020 Mar 17;10(3):463. doi: 10.3390/biom10030463. Biomolecules. 2020. PMID: 32192191 Free PMC article.
-
Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?Front Genet. 2014 Nov 14;5:391. doi: 10.3389/fgene.2014.00391. eCollection 2014. Front Genet. 2014. PMID: 25452763 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous